We believe that the role of EPHB2 in antifungal signaling is very important, and it will provide a novel target for the treatment of fungal infection and autoimmune diseases, as we have provided evidence that two existing drugs Vandetanib and Dasatinib can inhibit T helper cell differentiation in vivo and diminish mice EAE severity. This evidence concerns the gene EPHB2 and fungal infectious disease.